Also, IL-6 (Figure 5C) serum levels were significantly increased and IFN-γ (Figure 5G) as well as TGF-β1 (Figure 5S) levels were higher in most ADA-negative but not in ADA-positive FD patients under ERT (p=0.06). This evidence concerns the gene IL6 and Fabry disease.